Alterity Therapeutics ATHE
NASDAQ ATHE
$2.31 +0.01 (+0.43%)
As of: Nov 11, 2026 · 3:59 PM EST

Alterity Therapeutics (ATHE) Current Deferred Revenue (2012 - 2013)

Updated

Alterity Therapeutics' Current Deferred Revenue was $30,924 in the quarter ended Dec 31, 2013, down 41.4% from $52,778 a year earlier but up 1.3% from the prior quarter.

Analysis

Alterity Therapeutics (ATHE) Current Deferred Revenue (2012 - 2013) Analysis & Trends

As of Jun 30, 2013, Current Deferred Revenue at Alterity Therapeutics came in at $34,240, down 33.3% from the prior year.

  • In earlier years, Current Deferred Revenue was $51,366 in the year ended Jun 30, 2012.
  • Quarterly Current Deferred Revenue has moved between $30,540 (the quarter ended Oct 1, 2013) and $52,778 (the quarter ended Dec 31, 2012) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Alterity Therapeutics 42.05 Mn -41.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 29,731.51
Oct 1, 2013 31,067.20
Jun 30, 2013 30,937.44
Dec 31, 2012 52,823.51
Oct 2, 2012 52,665.88
Jun 30, 2012 51,002.37
API Access

Alterity Therapeutics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ATHE&period=max&api_key=YOUR_API_KEY